RCLS – Tackling the Increase of Gonorrhoea and Syphilis

RCLS – Tackling the Increase of Gonorrhoea and Syphilis

A report published by Public Health England (PHE) reveals that there was 7,137 diagnoses of syphilis reported in 2017, a 20% increase compared to 2016 and 44,676 diagnoses of gonorrhoea reported in 2017, a 22% increase compared to 2016.1

Overall, there were 422,147 diagnoses of sexually transmitted infections (STIs) in England during 2017.

To help with the increase of STI testing, Randox Clinical Laboratory Services offer a multiplex Sexually Transmitted Infection (STI) test kit allowing your clinic, laboratory or GP practice to outsource sample STI testing.

Our STI array is the broadest IVD multiplex array on the market simultaneously detecting 10 infections due to our patented and intelligent Biochip Array Technology which utilises multiplex testing methodology in a rapid and accurate format. These 10 bacterial, viral and protozoan infections consist of:

·        Chlamydia ·        Trichomonas Vaginalis
·        Gonorrhoea ·        Mycoplasma Hominis
·        Syphilis ·        Mycoplasma Genitalium
·        Herpes Simplex 1 ·        Ureaplasma Urealyticum
·        Herpes Simplex 2 ·        Chancroid

 

The type of sample which should be sent to our Randox Clinical Laboratory Service lab is determined by the visibility of the patient’s symptoms.

Non-visible symptoms – urine sample required

Visible symptoms – swab sample required

The process of sending samples to RCLS is simple and easy to follow. Our project management teams incorporate a wealth of knowledge and are available accordingly, providing support and guidance. This enables support to be available from your initial enquiry through to the shipment of the samples. As a result we are always delivering to your project aims and timelines.

RCLS currently has four state of the art, fully functional ISO12025 accredited laboratories across the UK. They are situated in Liverpool, London and two in Northern Ireland, Hollywood and Randox Science Park in Antrim.

Overall, by utilising Randox Clinical Laboratory Services you can save your laboratory time and money. Due to our multiplex panels we offer a cost effective, labour saving and time reducing solutions for your STI testing. Providing your laboratory with the best solution to outsource your samples.

Contact us at info@rcls.com to find out more information about RCLS and our STI testing service.

Sources
1 – Public Health England

 

 

 


Your outsourcing solution enhanced by Randox Biochip Array Technology

Randox Clinical Laboratory Services (RCLS) strives to provide a clinical laboratory service to meet the time sensitive, bespoke requirements of research and clinical projects globally.

RCLS utilises the expertise and knowledge Randox has built up over 35 years producing high quality IVD products. Many years of development and the expertise of highly qualified scientists from Randox has been invested to create the Biochip Array Technology (BAT) – a multi-analyte testing platform facilitating the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample.

Biochip Array Technology provides a unique platform for assessment of biological samples in a rapid, accurate and easy to use format and users can have the utmost confidence in this proven technology.

A chemically activated 9x9mm ceramic biochip acts as a solid phase reaction vessel. Biochips are pre-fabricated with discrete test regions (DTRs); a different antibody/oligonucleotide is immobilised at each spatially distinct DTR. Up to 49 individual DTRs can be arrayed on to a single biochip with one biochip per sample used to generate multiple results simultaneously.

This eliminates the need to run costly, time consuming and sample intensive single analyte assays. The biochip detection is based on a chemiluminescent signal emitting light, without heat, as a result of a chemical reaction. The light emitted is simultaneously detected and quantified using a CCD camera.

Overall, by utilising Randox Clinical Laboratory Services you can save your laboratory time and money. Due to our multiplex panels we offer a cost-effective, labour-saving and time-reducing solutions for your sample testing. As a result we provide your laboratory with the best solution to outsource your sample.

If you would like to find out more information about RCLS you can visit dev.randox.com/rcls

Or for any additional questions on what it has to offer you can email the RCLS team at info@rcls.com

 

 

 

 


Randox Clinical Laboratory Services: Experienced Staff Dedicated to Meeting Your Outsourcing Needs

With Lab Week occurring this week, RCLS wants to take the opportunity to draw recognition to their dedicated and experienced team of scientists who enable you to meet the time sensitive, bespoke requirements of your research and clinical projects globally. Lab Week occurs annually to celebrate medical laboratory professionals and pathologists who play a vital role in health care and patient advocacy.

Specialising in biomarker and multiplex testing in addition to standard safety and clinical testing, RCLS provides a full laboratory service to accelerate your project to completion. Our experienced project management teams are available to provide support and guidance from initial biomarker selection through to the design of a comprehensive results data package to deliver against your project aims and timelines.

Flexibility and quality are at the core of our service offering. Our in-house biotechnology group enables custom development and scale up monoclonal and polyclonal antibodies, antibody fragments (Fab’s, ScFv’s, sdAb’s) and recombinant proteins to meet your laboratory needs.

Currently, there are four state of the art, fully functional ISO12025 accredited laboratories, located in Liverpool, London, Holywood and the Randox Science Park in Antrim. In addition, two laboratories are underway in Los Angles and Dubai. These additions will give RCLS the ability to increase output to both the pharmaceutical, health and research market.

Renowned for quality and reliability, the RX Series and Evidence series are utilised by all RCLS Laboratories, guaranteeing real cost savings, highly accurate and flexible testing solutions. Furthermore, RCLS perform sample testing on numerous third party analysers situated in our laboratories dependent upon the testing which is required by the customer.

Overall, the RCLS team aim to save your laboratory time and money. By utilising our multiplex panels, RCLS can offer labour saving, time reducing and cost effective solutions for all your laboratory testing. Providing your laboratory with the best solution to outsource your testing.

If you would like to find out more information about RCLS and what it has to offer contact info@rcls.com or visit our website www.rcls.com

[mpc_cubebox transition_duration=”500″ front_background_color=”#f29760″ side_background_color=”#88d482″ mpc_ribbon__font_preset=”mpc_preset_101″ mpc_ribbon__text=”RX series 123″][mpc_cubebox_side title=”Front” tab_id=”1523963345262-7″][/mpc_cubebox_side][mpc_cubebox_side title=”Side” tab_id=”1523963345448-10″][/mpc_cubebox_side][/mpc_cubebox]


Randox Clinical Laboratory Services: Your STI Outsourcing Solution

Have you heard about our latest offering? Randox Clinical Laboratory Services now offers a multiplex Sexually Transmitted Infection Array testing service allowing your clinic, laboratory or GP practice to outsource sample STI testing.

Our STI array is the broadest multiplex test on the market, simultaneously detecting 10 bacterial, viral and protozoan infections. It consists of  the following most common STIs, Chlamydia, Gonorrhoea, Syphilis, Herpes Simplex I, Herpes Simplex II, Trichomonas Vaginalis, Mycoplasma Hominis, Mycoplasma Genitalium, Ureaplasma Urealyticum and Chancroid. This simultaneous detection is made possible by our patented and innovative Biochip Array Technology which utilises multiplex testing methodology in a rapid and accurate format.

There are many benefits to outsourcing your STI samples with RCLS, which include:

  • CE-marked
  • ISO17025 Accredited Laboratories
  • Excellent precision, specificity, sensitivity and accuracy for STI diagnosis
  • Reduced risk of false reporting and a reduced number of unnecessary confirmatory tests
  • Smaller sample volumes are required, enabling faster throughput and rapid patient diagnosis

The type of sample which should be sent to our RCLS lab is determined by the visibility of the patient’s symptoms.

Non-visible symptoms – urine sample required.

Visible symptoms – swab sample required.

The process for sending STI samples to Randox Clinical Laboratory Services is simple and easy to follow. Georgia Roberts, our RCLS representative will guide you through the process from your initial enquiry to pricing and shipment of samples.

All RCLS laboratories utilise our world class clinical chemistry analysers, the RX Series, along with our multiplex immunoassay analysers, the Evidence Series. We also perform sample testing on numerous third party analysers situated in our laboratories dependent upon the testing which is required by the customer.

RCLS incorporates multiple laboratories across the United Kingdom including our state-of-the-art facility in Antrim, as well as further laboratories in Belfast, Liverpool and London. RCLS is ever expanding with plans to open another facility in Los Angeles.

Overall, by utilising Randox Clinical Laboratory Services you can save your laboratory time and money. Due to our multiplex panels we offer a cost effective, labour saving and time reducing solutions for your STI testing. Providing your laboratory with the best solution to outsource your samples.

If you would like to find out more information about RCLS and what it has to offer contact info@rcls.com

 

 

 


RCLS: Flexibility and Quality at the Core of Service

Randox Clinical Laboratory Services is a dedicated group of laboratories across the United Kingdom with plans to expand across the world. All of the clinical laboratories are purpose built to deal with the bespoke needs of research and clinical projects. Currently we have laboratories situated in Antrim, Holywood, Liverpool and London.

Flexibility and quality are at the core of our service offering and our experienced team are available to support and advise at each step of a project to ensure deadlines are met and high quality data is delivered in the most cost efficient manner.

Specialising in biomarker and multiplex testing in addition to standard safety and clinical testing, RCLS provides a full laboratory service to accelerate your project to completion. Our patented and globally recognised Biochip Array Technology (BAT), provides multiplex testing solutions in an accurate and precise format. Vast expertise in in-house antibody and assay development also allows for customised assays to be incorporated into your testing.

A key focus for RCLS, utilising this technology (BAT) and the ability to customise, is esoteric/niche biomarker analysis within clinical trials. Randox has been providing custom assay design, development and manufacturing services to the diagnostic, pharmaceutical, contract research and biotech industries for many years. This also includes fully customised human and animal quality control sera. We have the facilities to design a novel multiplex biochip tailored to each customer’s requirements taking into account sample types, available sample volumes and expected ranges for various analytes of interest.

Our assay development specialists will endeavour to work with you to ensure your needs are constantly met and provide a smooth process from the time of your first enquiry through to final delivery.

If you would like more information on RCLS please contact info@rcls.com


Randox Clinical Laboratory Services: Accelerating Your Clinical Trial

Randox Clinical Laboratory Services is built upon Randox’s 35 years as an invitro diagnostics company, and is on hand to assist your drug discovery ensuring the toxicity and efficacy of your drug before proceeding to Phase 1 of your clinical trial.

RCLS currently has four state of the art, fully functional ISO12025 accredited laboratories across the UK. They are situated in Liverpool, London and two in Northern Ireland, Hollywood and Randox Science Park in Antrim.

RCLS looks to expand their team of experienced scientists, working towards further accreditations and furthermore setting up two additional labs in Dubai and Los Angeles. The addition of these purpose-built labs will give RCLS the ability to increase output to both the pharmaceutical, health and research market.

The RCLS laboratories offer unrivalled sample management and workflow with a unique identifier and sample traceability allowing patient history to be 100% accurate and guaranteed. The storage locations of sample are located separately with a duration of 15-25 years in fire proof cabinets. The sample rejection criteria and sample destruction processes are different from diagnostics standards as we offer multiple bar coding, sample manifests dictated by LIMS and double blinding of samples undergoing genomic testing.

A variety of analysers are situated across all RCLS laboratories not only including our RX Series and Evidence Series of multiplex immunoassay analysers but also third party analysers ensuring the testing abilities are diverse. The equipment covers chemistry, haematology, urinalysis and immunoassay testing capabilities.

With a greater understanding of human complexity, pharmaceutical companies are now focusing on developing safer drugs tailored to specific patient groups or sub-groups and the expansion plans in motion at RCLS will help these organisations bring new drugs to the market quicker.

If you would like more information on RCLS please contact info@rcls.com


RCLS – at the cutting edge of laboratory innovation

Randox Clinical laboratory Services (RCLS) is the latest offering from Randox, Built over 35 years of experience producing high quality IVD products, Randox Clinical Laboratory Services (RCLS), is dedicated to providing a clinical laboratory service designed to meet the time sensitive, bespoke requirements of research and clinical projects globally.

RCLS currently has four state of the art, fully functional ISO12025 accredited laboratories across the UK. They are situated in Liverpool, London and two in Northern Ireland, Hollywood and Randox Science Park in Antrim. RCLS looks to expand their team of experienced scientists, working towards further accreditations and furthermore setting up two additional labs in Dubai and Los Angeles. The addition of these purpose built labs will give RCLS the ability to increase output to both the health and research market.

Ann-Marie Jennings, Laboratory Manager for Randox Clinical Laboratory Services, discusses the Randox Biochip Array, RCLS’ abilities and confidence in testing;

“On our patented Randox Biochip Array Technology we can customize bespoke testing platforms based on the requirements of each drug development project, which can be a challenging process. From initial product development to clinical trial stages there can be a number of barriers and time constraints before drugs are successfully released to the public.  We’re confident that our newly enhanced capabilities will benefit patients suffering from conditions in most need of research by offering pharmaceutical companies at the forefront of pioneering research, with the latest technological developments.”

Thanks to these state of art laboratories, RCLS will now be able to provide an increasingly wide range of testing services to Biotechnology, research and pharmaceutical companies delivering the testing services required to support their research and drug development projects.

With the ability to conduct an unrivalled range of health testing – haematology, biochemistry and immunoassay – all under one roof, the laboratory offers unparalleled support services to the dynamic and growing healthcare industry.  With a greater understanding of human complexity, pharmaceutical companies are now focusing on developing safer drugs tailored to specific patient groups or sub-groups and the expansion plans in motion at RCLS will help these organisations bring new drugs to market faster.

If you would like more information on Randox Clinical Laboratory Services, please contact us by emailing us at info@rcls.com

 


What is RCLS? Randox Clinical Laboratory Services Explained

Randox Laboratories has over 35 years’ experience producing high quality IVD products. Randox Clinical Laboratory Services (RCLS), has built upon this experience and is Randox’s latest offering, dedicated to providing a clinical laboratory service designed to meet the time sensitive, bespoke requirements of clinical and research projects globally.

Facilities and Analysers

RCLS is a state of the art ISO 17025 accredited central laboratory with unrivalled facilities. A knowledgeable and proficient team is situated at each of the three locations.

There are a variety of analyser platforms available across the RCLS laboratories including the RX series of clinical chemistry analysers along with our Evidence Series of multiplex immunoassay/molecular diagnostic systems which utilise our intelligent Biochip Array Technology.  Each site also offers alternative third party analysers.

The Process

RCLS has the capability to collect your samples for testing via our third party courier service. The samples will then arrive at your chosen facility where they will be labelled with a unique identifier and uploaded onto our 21 CFR Part II compliant LIMS system. Full sample traceability is guaranteed through our integrated LIMS system. Short and medium term sample storage at -20 and -80 is also available.

Once each sample has been tested you will receive your results. We are flexible with the data transfer options available, which include couriered CD/USB, a secure email or alternatively uploaded to a sponsor database or server. Your sample results can be sent via a method which is convenient for you.

Capabilities

The capabilities of Randox Clinical Laboratory Services incorporate over 220 clinical and safety tests, 300 biomarkers and 80 Biochip Array Technology multiplex panels built in-house. We offer molecular arrays across a variety of disease such as our Sexually Transmitted Infection array. We also offer comprehensive ELISA project capabilities, selecting and validating the most appropriate reagent to match individual requirements. If you require your samples to be tested as part of a clinical trial or a research project we are on hand to help accelerate your project.

If you would like more information on Randox Clinical Laboratory Services, please contact us by emailing us at info@rcls.com


Cutting-edge research and testing centre opens at Randox Science Park

Following the success of the first ever Randox Health Grand National, global health diagnostics company Randox has today announced the official opening of its new central laboratory, Randox Clinical Laboratory Services (RCLS), at the recently acquired Randox Science Park in Antrim, Northern Ireland.

Situated at this new state of the art biohub, the RCLS accredited lab now houses Randox’s latest blood screening equipment – the pioneering Evolution machine.  This new technology enables the labs to conduct a full range of niche and standard research testing, as well as current health testing for the company’s Randox Health division, which offers the world’s most comprehensive full body health analysis.

Research areas at the newly accredited laboratory include but are not exclusive to cancer, fertility, heart, inflammation, stroke and kidney health, both in-house and collaboratively with external organisations.  Current and past collaborations include an Acute Kidney Injury Study with the Royal Victoria Hospital, a Bladder Cancer Study in partnership with Queen’s University Belfast and The Belfast Trust, a Stroke and Brain Injury study with Cambridge University, and key partnerships with a number of major pharmaceutical companies.

A staggering 222 clinical diagnostic tests are currently run routinely with the lab, with more tests pending accreditation in the coming months.

Ann-Marie Jennings, Laboratory Manager for Randox Clinical Laboratory Services, explained that the new facilities will allow RCLS to increase their output and enter new markets;

“Randox Clinical Laboratory Services has been operational for a number of years in our headquarters in Crumlin, near the Belfast International Airport.  Now that we have moved to our new, purpose-built labs in the Randox Science Park, we have the ability to increase the output of both our health testing and our research testing. This involves expanding our team of experienced scientists, working towards further accreditations and furthermore setting up independent labs in Dubai, LA, Holywood and Liverpool in addition to our current labs in Antrim and London.”

Thanks to the new Randox Science Park facilities, the company will now be able to provide an increasingly wide range of testing services to Biotechnology and In Vitro Diagnostic companies, and will deliver to pharmaceutical companies the testing services required to support their drug development projects, in addition to the testing provided to research organisations,

With the ability to conduct an unrivalled range of health testing – haematology, biochemistry and immunoassay – all under one roof, the laboratory offers unparalleled support services to the dynamic and growing healthcare industry.  With a greater understanding of human complexity, pharmaceutical companies are now focusing on developing safer drugs tailored to specific patient groups or sub-groups and the expansion plans in motion at RCLS will help these organisations bring new drugs to market faster.

Ann-Marie continued;

“On our patented Randox Biochip Array Technology we can customize bespoke testing platforms based on the requirements of each drug development project, which can be a challenging process. From initial product development to clinical trial stages there can be a number of barriers and time constraints before drugs are successfully released to the public.  We’re confident that our newly enhanced capabilities will benefit patients suffering from conditions in most need of research by offering pharmaceutical companies at the forefront of pioneering research, with the latest technological developments.”

For more information about RCLS please contact Randox PR on 028 9442 2413 or email RandoxPR@randox.com


Clinical Laboratory Survey